(5 years, 5 months ago)
Commons ChamberThe independent review of drugs misuse to which the hon. Gentleman refers is, I think it is fair to say, the most comprehensive review that has ever been commissioned on such a subject by a Government. It has a broad remit and, when Dame Carol Black reports back—I think there will be an interim report this summer—we will take it very seriously.
(6 years, 5 months ago)
Commons ChamberI can absolutely give my hon. Friend that reassurance. The review must have the patient at its very heart and must be driven by medical evidence.
I welcome the statement, and particularly the news on Alfie Dingley. Of course, there is already evidence of the medical benefits of cannabis, because otherwise Sativex would not be available on licence. That is why it is so absurd that cannabis is still a schedule 1 controlled drug. I am therefore hopeful and confident that the review will lead to a recommendation to reschedule. Will the Secretary of State confirm that rescheduling could be carried out quite quickly and easily by means of a statutory instrument, meaning that we can get on with it?
First, Sativex was looked at for a particular condition. It is right that drugs are looked at the context of the condition that they are intended to help with. The hon. Gentleman makes a good wider point about whether, once the review is complete, we can get on with it, with any changes made quickly. That is exactly what I intend to do.